Tenofovir: Clinical Trials

4 trials for Tenofovir, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 not yet recruiting. 4 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Not yet recruiting 2
Phase 12Not yet recruiting 2

Follow Tenofovir: new trials by email Literature Review of Tenofovir trials Research Report on Tenofovir

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the Treatment of EBV-associated Diseases.
PD-1 Inhibitor Combined with Tenofovir, Chidamide, and Lenalidomide for the Treatment of EBV Infectious Diseases. - Epstein-Barr Virus (EBV) Infection, PD-1 Inhibitor
Phase 1 / Phase 2Not yet recruitingThe Affiliated Hospital of Xuzhou Medical University302025-09-012025-08-21
Application of PD-1 Inhibitors, Tenofovir, Chidamide, and Lenalidomide in Relapsed/Refractory EBV-associated Lymphoproliferative Disorders.
PD-1 Inhibitor Combined with Tenofovir, Chidamide, and Lenalidomide for the Treatment of EBV-Associated Lymphoproliferative Disorders. - EBV-Associated Lymphoproliferative Disorders, PD-1 Inhibitor
Phase 1 / Phase 2Not yet recruitingThe Affiliated Hospital of Xuzhou Medical University502025-09-012025-08-21
CROSSOVER STUDY OF ON-DEMAND PREP FORMULATIONS COMPARING RECTAL AND ORAL TENOFOVIR
Oral F/TDF Pills, TFV rectal douche - Tenofovir
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1502024-10-292026-10-23
Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B.
Tenofovir Disoproxil Fumarate - Hepatitis B, Tenofovir
Phase 2CompletedUniversity of Oxford272021-01-082024-03-27

Narrower conditions

Epstein-Barr Virus Infections (1)  ·  Hepatitis B (1)  ·  Infections (1)

Broader conditions

DNA Virus Infections (2)  ·  Virus Diseases (2)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Digestive System Diseases (1)  ·  Hepadnaviridae Infections (1)  ·  Hepatitis (1)  ·  Hepatitis, Viral, Human (1)  ·  Herpesviridae Infections (1)  ·  Infections (1)  ·  Liver Diseases (1)  ·  Tumor Virus Infections (1)

Interventions

Tenofovir (3)  ·  Lenalidomide (2)  ·  N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide (2)

Sponsors

The Affiliated Hospital of Xuzhou Medical University (2)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  University of Oxford (1)

Countries

Thailand (1)  ·  United States (1)